Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) Research Peptide
Tirzepatide is a 39-amino-acid dual receptor agonist research peptide that activates both GLP-1 and GIP receptors, studied for dual incretin pathway signalling research. Supplied as a lyophilized vial in 5-30mg sizes, for in-vitro laboratory research use only.
- Class: Dual GIP/GLP-1 agonist · Half-life: ~5 days (literature-reported)
- Available sizes: 5mg, 10mg, 15mg, 20mg, 30mg
- Purity: ≥99% HPLC, third-party tested, COA included
- Shipping: USA same-day (before 2pm CT M-F) · free over $200
Related: Semaglutide · Retatrutide
For laboratory research use only. Not for human or animal consumption. Full details ↓
$ 99.00 – $ 250.00Price range: $ 99.00 through $ 250.00
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 89.10 | 10% |
| 6-9 | $ 84.15 | 15% |
| 10+ | $ 79.20 | 20% |
Add $ 200.00 to cart and get free shipping!
Description
Tirzepatide is a 39-amino-acid dual GLP-1/GIP receptor agonist research peptide, activating both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. LiveWell supplies it as a lyophilized vial strictly for in-vitro laboratory research — it is not for human or animal consumption.
Chemical information
- Sequence length: 39 amino acids
- Class: Dual GIP/GLP-1 receptor agonist
- Half-life: ~5 days reported in published literature
- Available sizes: 5mg, 10mg, 15mg, 20mg, 30mg
Why dual-receptor activity is studied
Unlike single-target GLP-1 agonists, Tirzepatide engages both the GLP-1 and GIP receptors, a dual-agonist profile that is examined in comparative research against single-receptor compounds. Smaller vials (5-10mg) suit controlled in-vitro testing of receptor-binding dynamics, while larger vials (15-30mg) suit extended studies of dual receptor signalling mechanisms.
Studied in
- Comparative GLP-1 vs dual-agonist receptor research
- Receptor-binding affinity comparison studies
- Dual incretin pathway signalling research
- Glucose and lipid metabolism pathway studies in cell-based models
Storage & handling
- Store the lyophilized vial refrigerated at 2–8°C, protected from light and heat
- Reconstitute with bacteriostatic water; reconstituted material has a shorter storage window
- Follow your laboratory’s standard peptide handling protocol
⚠️ Disclaimer: Tirzepatide research peptide is intended strictly for laboratory research and in-vitro use only. It is not a drug, food, cosmetic, or dietary supplement, has not been evaluated or approved by the FDA, and is not for human or veterinary use. No therapeutic, weight-management or metabolic-health claims are made or implied.
Regulatory status: Tirzepatide is the active ingredient in FDA-approved prescription medications. The research-grade material sold by LiveWell is not a drug product — it is not manufactured, compounded, or approved for pharmaceutical use, and is strictly for in-vitro laboratory research. It is not a substitute for any prescription medication, and nothing on this page constitutes medical advice.
Research reference: View study on PubMed
Buy Tirzepatide Research Peptide — cGMP Manufactured in Dallas, TX
LiveWell Peptides manufactures research-grade Tirzepatide in our cGMP facility in Dallas, Texas. Every vial is third-party tested to verify ≥99% HPLC purity, amino acid identity, and endotoxin levels, with a full COA published on our COA page. US orders before 2pm CT (Mon–Fri) ship same-day, with free domestic shipping over $200.
Why Researchers Source Tirzepatide from LiveWell
Documentation, not claims. Every batch ships with a verified COA confirming identity and purity, published on our COA page.
Four-point analytical testing. HPLC for purity, mass spectrometry for amino acid identity, and LAL testing for endotoxins.
US manufacturing and cold-chain logistics. Orders ship same-day from our Dallas, Texas facility, with international shipping to Colombia, Mexico, Brazil, Argentina, Chile and Peru.
Related research compounds
Semaglutide (GLP-1) · Retatrutide (Triple GLP-1/GIP/Glucagon) · Orforglipron · Bacteriostatic Water · Certificates of Analysis
Research literature
Tirzepatide has been the subject of 1,927 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference:
- Soliman A et al. (2026). Tirzepatide as adjunct therapy in patients with type 1 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. PMID: 41883513
References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a 39-amino-acid dual GLP-1/GIP receptor agonist research peptide. Supplied as a lyophilized vial strictly for laboratory research use only.
How does Tirzepatide differ from Semaglutide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist, while Semaglutide is a single GLP-1 receptor agonist. The additional GIP receptor activity is the primary mechanistic distinction studied in comparative research.
How does Tirzepatide differ from Retatrutide?
Tirzepatide activates two receptors (GLP-1, GIP). Retatrutide activates three (GLP-1, GIP, and glucagon), studied for its broader receptor-engagement profile in comparative research.
What purity is LiveWell Tirzepatide, and is a COA included?
Every batch is third-party tested at ≥99% purity by HPLC, with mass spectrometry identity confirmation and LAL endotoxin testing. A full Certificate of Analysis is included.
How should Tirzepatide be stored and reconstituted?
Store refrigerated at 2–8°C, protected from light and heat. Reconstitute with bacteriostatic water; reconstituted material has a considerably shorter storage window.
Is Tirzepatide a drug or supplement?
No. Tirzepatide research peptide is a research compound sold strictly for laboratory use only. It is not a drug, dietary supplement, food or cosmetic.
Péptidos de investigación disponibles con envío internacional. Tirzepatida de grado de investigación fabricada en instalaciones cGMP en Dallas, Texas. Certificado de análisis incluido con cada pedido. Solo para uso en investigación.
Research Use Only Disclaimer: This product is sold strictly for in vitro laboratory research. NOT for human or animal consumption. LiveWell Peptides makes no medical claims.
You may also like
